Maxwell Enterprises

• Osteofos 70mg tablets for once weekly administration
• Osteofos 10mg tablets for once daily administration

Eukroma (Hydroquinone) is a skin-bleaching agent that is used to lighten areas of darkened skin such as freckles, chloasma (also known as melasma), age spots, and acne scars.

Hydroquinone decreases the formation of melanin in the skin. Melanin is the pigment in skin that gives it a brown color.

Hydroquinone topical is used to lighten areas of darkened skin such as freckles, age spots, chloasma, and melasma.

Hydroquinone topical may also be used for other purposes not listed in this medication guide.

• Ovral L - Product Information Ovral L is a monophasic, low dose combination of Levonorgestrel and Ethinylestradiol Tablets I.P. used to prevent pregnancy. Each combined oral contraceptive (COC) tablet contains 150 µg of Levonorgestrel I.P. and 30 µg of Ethinyl estradiol.
• Active Pharmaceutical Ingredient in Ovral LThe active pharmaceutical ingredients in Ovral L are levonorgestrel I.P. 150 µg (0.15 mg) and ethinyl estradiol I.P. 30 µg (0.03 mg).
• Uses of Ovral LOvral L is used to prevent pregnancy.
• Dosage and Administration Take one pill of Ovral L daily at the same time for 21 consecutive days. Start taking the next pack of 21 tablets after 7 days.
• How to start Ovral L
• If you have not used an oral contraceptive in the previous month:
• Take the first tablet on day 1 of your natural cycle, i.e. on the first day of your period.
• If you start on day 2-7, you will have to use for the first seven days an additional nonhormonal method of birth control (such as ).
• If you have used before another oral contraceptive:
• Start taking Ovral L on the day after the last tablet of your previous pill, latest on the day following the usual tablet-free (or inactive tablet) interval.
• Changing from a progestin only method (progestin-only pill, injection, implant)
• You may switch any day from the progestin-only pill and begin Ovral L the next day. Start Ovral L on the day of an implant removal or, if you used an injection before, the day the next injection would be due.
• It is advised to use an additional protection for the first 7 days.
• Do not start taking Ovral L before 28 days after delivery.
• Drug Class and Mechanism Ovral L belongs to the group of oral contraceptives.
• Ovral L acts by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increases the difficulty of spermS entry into the uterus) and in the endometrium (which reduces the likelihood of implantation).

• If you miss one tablet, but not more than 12 hours have passed, take the tablet as soon as you remember. Take the next tablet at the usual time.

• If you miss one tablet, and more than 12 hours have passed, or if you missed more than one tablet, your protection against pregnancy may be reduced.. The last missed tablet should be taken as soon as you remember, even if this means taking two tablets in one day. Subsequent tablets should be taken at the usual time. In addition, a nonhormonal back-up method of birth control should be used for the next seven days.

• If two tablets in a row are missed in week 1 or week 2 of a pack, two tablets should be taken on the day you remember, and two tablets the next day. Subsequent tablets should be taken at the usual time. In addition, a nonhormonal back-up method of birth control ( such as ) should be used for the seven days after tablets are missed.

• If two active tablets in a row are missed in week 3 of a pack, or if three or more tablets in a row are missed in weeks 1-3 of a pack, discard the rest of the packet and start a new packet the same day. Use additional methods to prevent pregnancy.
• Storage Of Ovral L TabletsStore Ovral L at room temperature away from heat and moisture. Keep out of reach of children and pets. Store in a cool place.

NICOTINE 2MG CHEWING GUMS

TYPICAL USAGE:  withdrawal.

SIDE EFFECTS: Hyperglycemia, increased blood lactate, hypoinsulinemia, epileptic seizures, sweating, respiratory arrest, tremor, hyperpnea, palpitation, sweating, tremor, faintness, paresthesias, pallor.

DRUG INTERACTION: Nicotine is known to interact with other drugs like insulin, papaverine (HCl), , theophylline. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

NICOTINE 2MG CHEWING GUMS

TYPICAL USAGE:  withdrawal.

SIDE EFFECTS: Hyperglycemia, increased blood lactate, hypoinsulinemia, epileptic seizures, sweating, respiratory arrest, tremor, hyperpnea, palpitation, sweating, tremor, faintness, paresthesias, pallor.

DRUG INTERACTION: Nicotine is known to interact with other drugs like insulin, papaverine (HCl), , theophylline. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Additional Information:

• Item Code: COT-7287367

• Positive results
• Hygienic packing
• Safe to use

• Purity
• Precise pH value
• Safe to consume

Additional Information:

• Item Code: CLT-7867

Additional Information:

• Item Code: OED-6176

Budesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Additionally, it is used for Crohn''s disease (inflammatory bowel disease).
 It is marketed by AstraZeneca as a nasal inhalant under the brand name Rhinocort (in Denmark, as Rhinosol), as an oral inhalant under the brand name Pulmicort, and as either an enema or a modified release oral capsule under the brand name Entocort. It is also sold in combination with (Oxis) in a single inhaler, under the brand name Symbicort. In Brazil it''s marketed by Eurofarma under the brand name Noex.

Budesonide controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes, fibroblasts, reverses capillary permeability and lysosomal stabilisation at the cellular level to prevent or control inflammation.
Absorption: Rapid and almost complete after oral admin but has poor systemic availability.
Metabolism: Undergoes first-pass metabolism.

Information Not Available

Loss of skin collagen and SC atrophy; local hypopigmentation of deeply pigmented skin; dryness, irritation, epistaxis, rarely ulceration or perforation of the nasal septum; smell and taste disturbances; hoarseness and candidiasis of the mouth or throat.

Methotrexate, abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug used in treatment of cancer and autoimmune diseases. It acts by inhibiting the metabolism of folic acid. Methotrexate began to replace the more powerful and toxic antifolate aminopterin starting in the 1950s, and the two should not be confused with each other.

Methotrexate is a folic acid antagonist that inhibits DNA synthesis. It irreversibly binds to dihydrofolate reductase, inhibiting the formation of reduced folates, and thymidylate synthetase, resulting in inhibition of purine and thymidylic acid synthesis.

Additional Information:

• Item Code: CIT-69061186